Key facts
- OncoRes Medical’s last known valuation is $24.1M (May 2025).
- It has raised $40.0M; the latest was Later Stage VC ($18.6M) in Feb 2026.
- Notable investors include MedTech Innovator, Texas Medical Center, Brandon Capital, ANDHealth, Government of Western Australia — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for OncoRes Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for OncoRes Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About OncoRes Medical
Developer of an intraoperative imaging tool designed to upgrade the standard of care in breast cancer surgery. The company's technology utilizes a novel combination of optical coherence tomography imaging, improving surgical accuracy and reducing complication rates and intraoperative complications, enabling surgeons to identify a tumor and healthy tissue.
- Sector
- Healthcare
- HQ
- Nedlands, Australia
- Founded
- 2016
- Employees
- 40
- Website
- oncoresmedical.com/
- Ownership
- Privately Held (backing)
OncoRes Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in OncoRes Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on OncoRes Medical in its N-PORT filings yet. We sweep new filings monthly.